Oxford Wealth Group’s Teladoc Health TDOC Stock Holding History

Oxford Wealth Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,389	Closed	-$180K	–	69
2024 Q2	$180K	Buy	+18,389	New	+$224K	0.12%	68

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oxford Wealth Group's TDOC Position: Q3 2024 in Review

Oxford Wealth Group sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 18,389 shares — an estimated $180K sold.

Oxford Wealth Group first reported a position in TDOC in Q2 2024 and held it in 1 quarter. The position peaked at $180K in Q2 2024. 365 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

Oxford Wealth Group reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
Oxford Wealth Group sold 18,389 Teladoc Health shares in Q3 2024, an estimated $180K.
Oxford Wealth Group first reported a position in Teladoc Health in Q2 2024 and held it in 1 quarter.
Oxford Wealth Group's Teladoc Health position peaked at $180K in Q2 2024.
365 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Oxford Wealth Group's 13F filing for Q3 2024, filed 12 Nov 2024.